Urges the United States Department of Veterans Affairs to study the effectiveness and use of hyperbaric oxygen therapy for veterans. (BDR R-838)
Impact
The resolution highlights the potential benefits of HBOT to enhance the health outcomes of veterans suffering from mild traumatic brain injuries and PTSD. Studies referenced in the bill indicate that veterans could see significant improvements in their symptoms from such treatments. The resolution aims to push the federal body to prioritize the exploration of this therapy within veteran health services, which could lead to changes in care protocols and treatment approval for conditions that currently lack effective treatment options.
Summary
AJR1 urges the United States Department of Veterans Affairs to study the effectiveness and use of hyperbaric oxygen therapy (HBOT) for veterans. This therapy involves breathing pure oxygen in a pressurized environment, aimed at increasing blood oxygen levels to aid in healing and combatting infections. While the FDA has approved HBOT for certain medical conditions, it has not sanctioned its use for treating PTSD and TBI, despite some studies suggesting positive outcomes in these areas. AJR1 seeks to spark further investigation into these benefits for veterans suffering from such conditions.
Contention
While there is a growing body of evidence suggesting the effectiveness of HBOT for PTSD and TBI, the bill's critics may argue about the need for rigorous clinical trials to substantiate these claims. The bill underscores the necessity for the Department of Veterans Affairs to conduct studies that would validate these treatments. The discussion around AJR1 may evoke debates regarding the allocation of research resources and whether alternative therapies should be integrated into traditional VA treatment frameworks.
A resolution to urge the United States Food and Drug Administration to facilitate FDA regulated research on hyperbaric oxygen therapy for the treatment of Traumatic Brain Injury and Post Traumatic Stress Disorder.
A CONCURRENT RESOLUTION urging Kentucky's Congressional delegation to include Kentucky's Veterans Affairs Medical Centers into the Center for Compassionate Innovation, a U.S. Department of Veterans Affairs pilot program enabling the use of hyperbaric oxygen therapy treatment for veterans with a traumatic brain injury or post-traumatic stress disorder.
TBI and PTSD Treatment Act This bill requires the Department of Veterans Affairs to furnish hyperbaric oxygen therapy through a provider authorized by the Veterans Community Care Program to veterans who have a traumatic brain injury or post-traumatic stress disorder.
TBI and PTSD Treatment Act This bill requires the Department of Veterans Affairs to furnish hyperbaric oxygen therapy through a provider authorized by the Veterans Community Care Program to veterans who have a traumatic brain injury or post-traumatic stress disorder.
A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans.(Formerly HF 479.)
A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(Formerly HF 326.)
A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans and making appropriations.(See HF 518.)
A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans.(See HF 574.)
A resolution to urge the United States Food and Drug Administration to facilitate FDA regulated research on hyperbaric oxygen therapy for the treatment of Traumatic Brain Injury and Post Traumatic Stress Disorder.